 | Arcturus Therapeutics (NASDAQ:ARCT) Downgraded by B. Riley to Sell
marketbeat.com - February 17 at 2:24 PM |
| Arcturus Therapeutics (NASDAQ:ARCT) Downgraded by Zacks Investment Research to Sell
marketbeat.com - January 26 at 5:07 PM |
 | Arcturus Therapeutics Holdings Breaks Below 200-Day Moving Average - Notable for ARCT
nasdaq.com - February 23 at 3:15 PM |
| Earnings Preview: Arcturus Therapeutics (ARCT) Q4 Earnings Expected to Decline
nasdaq.com - February 23 at 10:09 AM |
 | Arcturus Therapeutics (NASDAQ:ARCT) Shares Down 11%
americanbankingnews.com - February 22 at 10:00 PM |
 | Arcturus Therapeutics to Report Fourth Quarter and Year-End 2020 Financial Results and Provide Corporate Update on March 1, 2021
finance.yahoo.com - February 19 at 8:52 AM |
 | TransCode Therapeutics Announces Key Appointments
businesswire.com - February 18 at 1:02 PM |
| What's in the Cards for Arcturus (ARCT) This Earnings Season?
nasdaq.com - February 17 at 2:44 PM |
| Arcturus Therapeutics (NASDAQ:ARCT) Downgraded by B. Riley
americanbankingnews.com - February 17 at 2:25 PM |
 | Transthyretin Industry 2021 Demand, Market Trends, Regional Outlook, Top Manufacturers, Business Growth and Forecast to 2027 | Industry Research Biz
marketwatch.com - February 15 at 8:36 AM |
|
| Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Consensus Recommendation of "Hold" from Brokerages
americanbankingnews.com - February 13 at 8:49 AM |
| Arcturus Therapeutics (NASDAQ:ARCT) Shares Down 6.7%
americanbankingnews.com - February 12 at 8:18 PM |
 | Drugmakers Look for New Ways to Test Covid-19 Vaccines
wsj.com - February 11 at 1:29 PM |
| Arcturus Therapeutics (NASDAQ:ARCT) Shares Up 7.1%
americanbankingnews.com - February 4 at 7:50 PM |
| Brokerages Expect Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) to Post -$0.92 EPS
americanbankingnews.com - February 3 at 12:16 AM |
| Is the Options Market Predicting a Spike in Arcturus Therapeutics (ARCT) Stock?
finance.yahoo.com - January 28 at 1:27 PM |
| Is Arcturus Therapeutics a Buy?
finance.yahoo.com - January 12 at 9:50 AM |
| Why Arcturus Therapeutics Stock Skyrocketed Today
finance.yahoo.com - January 7 at 6:24 PM |
| Biotech Stock Roundup: MRNA's COVID-19 Vaccine Updates & Other Pipeline Updates
finance.yahoo.com - January 6 at 12:20 PM |
| Arcturus (ARCT) to Begin Phase II COVID-19 Vaccine Study
finance.yahoo.com - January 5 at 11:17 AM |
| Outlook for biotech companies in 2021
finance.yahoo.com - January 4 at 12:39 PM |
| Arcturus Therapeutics Receives FDA Allowance to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate in the United States
finance.yahoo.com - January 4 at 7:39 AM |
| Arcturus gets FDA go-ahead to begin Phase 2 trial for COVID-19 vaccine candidate
finance.yahoo.com - January 4 at 7:39 AM |
| Time to Go Bargain Hunting on Arcturus Stock? Analyst Weighs In
finance.yahoo.com - December 31 at 10:44 PM |
| Arcturus' (ARCT) Shares Fall on COVID-19 Vaccine Study Results
nasdaq.com - December 30 at 2:40 PM |
| Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Just Slashed Next Year's Revenue Estimates By 49%
nasdaq.com - December 30 at 9:40 AM |
| Markets Ease Lower as Arcturus, Blink Charging Plunge
finance.yahoo.com - December 29 at 5:52 PM |
 | Novavax Starts a Phase 3 Trial for Its Covid Vaccine, While Arcturus Gets 5 Downgrades for Its Stock
barrons.com - December 29 at 12:46 PM |
| Lemonade Stock Gains, Arcturus Therapeutics Tumbles as Stock Market Rally Continues
barrons.com - December 29 at 12:46 PM |
 | Return On Capital Employed Overview: Arcturus Therapeutics
benzinga.com - December 29 at 12:46 PM |
|
| Stock Alert: Arcturus Therapeutics Tanks Over 50%
nasdaq.com - December 29 at 12:46 PM |
 | Why Analysts Lost Confidence in the Arcturus COVID-19 Vaccine
msn.com - December 29 at 12:46 PM |
 | Arcturus Slumps Amid Analyst Pessimism on Vaccine
thestreet.com - December 29 at 12:46 PM |
| Arcturus Therapeutics shares slide 55% after COVID vaccine data are deemed ‘underwhelming’
marketwatch.com - December 29 at 12:46 PM |
| Apple, Quanterix, Arcturus: What to Watch When the Stock Market Opens Today
wsj.com - December 29 at 7:46 AM |
| Arcturus Gets Approval For Covid-19 Vaccine Phase 2 Study; Shares Plunge 38%
nasdaq.com - December 29 at 7:46 AM |
| Arcturus Therapeutics Received Approval from Singapore Health Sciences Authority to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate and Provides New and Updated Clinical and Preclinical Data
finance.yahoo.com - December 28 at 7:20 PM |
| Why Arcturus Therapeutics Stock Is Sinking Today
finance.yahoo.com - December 23 at 3:29 PM |
| 3 Incomparable Coronavirus Vaccine Stocks to Buy Right Now
finance.yahoo.com - December 20 at 7:40 AM |
| Is ARCT A Good Stock To Buy?
finance.yahoo.com - December 20 at 12:58 AM |
| Philippines can secure up to to 25 million doses of Moderna, Arcturus vaccines —envoy to US
msn.com - December 18 at 8:47 AM |
 | UPDATE 1-Philippines can secure up to 25 mln doses of Moderna, Arcturus vaccines-ambassador
reuters.com - December 18 at 8:47 AM |
| Philippines can secure up to 25 million doses of Moderna, Arcturus vaccines-ambassador
reuters.com - December 18 at 12:19 AM |
| 3 Top Coronavirus Stocks to Buy in December
finance.yahoo.com - December 13 at 7:23 AM |
| Why You Might Want to Buy This Potentially Game-Changing COVID Vaccine Stock Right Now
finance.yahoo.com - December 10 at 6:24 AM |
 | Thinking about trading options or stock in Arcturus Therapeutics, Boeing, Advanced Micro Devices, Omnicell, or Carnival Corp?
prnewswire.com - December 9 at 3:23 PM |
| Arcturus Therapeutics Announces Proposed Public Offering Of Common Stock; Size, Price Not Disclosed
benzinga.com - December 8 at 7:15 AM |
| Rainbows and Unicorns: Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Just Became A Lot More Optimistic
nasdaq.com - December 8 at 7:15 AM |
| Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
finance.yahoo.com - December 8 at 2:14 AM |
| Arcturus Therapeutics Announces Initiation of Dosing ARCT-810 in Patients with Ornithine Transcarbamylase (OTC) Deficiency
finance.yahoo.com - December 7 at 9:06 AM |
| Arcturus Therapeutics to Present at Upcoming Investor Conference
finance.yahoo.com - November 30 at 6:30 PM |
| Arcturus Therapeutics shares are trading higher after the company on Tuesday reported Q3 results.
benzinga.com - November 13 at 8:37 AM |
